Acasti Pharma Inc (APO.V)

APO.V on TSX Venture Exchange

0.61CAD
1:29pm EDT
Price Change (% chg)

$-0.03 (-4.69%)
Prev Close
$0.64
Open
$0.63
Day's High
$0.63
Day's Low
$0.61
Volume
13,200
Avg. Vol
50,503
52-wk High
$2.35
52-wk Low
$0.48

APO.V

Chart for APO.V

About

Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed... (more)

Overall

Beta: 0.69
Market Cap (Mil.): $68.01
Shares Outstanding (Mil.): 106.26
Dividend: --
Yield (%): --

Financials

  APO.V Industry Sector
P/E (TTM): -- 32.74 33.38
EPS (TTM): -0.09 -- --
ROI: -28.76 18.26 17.53
ROE: -32.42 18.93 18.34
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks